Strumento inattivo

Azioni Rennova Health Inc Nasdaq

Azioni

Durata

Periodo

Stile

RENNOVA HEALTH, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	24/07/20
RENNOVA HEALTH : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	17/07/20
RENNOVA HEALTH, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	08/07/20
RENNOVA HEALTH : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	29/06/20
RENNOVA HEALTH, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	16/06/20

Dirigenti	Titolo	Età	Da
Darrell Peterson CEO	Chief Executive Officer	65	14/05/23
Gerard Dab CHM	Chairman	75	14/05/23
Sebastien Sainsbury IRO	Public Communications Contact	61	-

Amministratori	Titolo	Età	Da
Gerard Dab CHM	Chairman	75	14/05/23
Sharon Hollis CEO	Chief Executive Officer	47	01/07/11
Francisco Roca BRD	Director/Board Member	58	14/05/23

Settore

	Variaz. 1 gen.	Capi.
SONIC HEALTHCARE LIMITED	-16,93%	8,36 Mrd
RADNET, INC.	+50,91%	3,84 Mrd
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-34,71%	2,64 Mrd
SYNLAB AG	-9,28%	2,48 Mrd
DR. LAL PATHLABS LIMITED	-9,39%	2,33 Mrd
NEOGENOMICS, INC.	-3,77%	1,98 Mrd
FLEURY S.A.	-17,29%	1,6 Mrd
DIAN DIAGNOSTICS GROUP CO.,LTD.	-36,54%	1,27 Mrd
METROPOLIS HEALTHCARE LIMITED	+5,98%	1,11 Mrd